Search Results - "Furubayashi, N."

Protein crystallization strategy in microgravity by Takahashi, S., Tanaka, H., Sato, M., Inaka, K., Yan, B., Yamanaka, M., Furubayashi, N., Sano, S., Kobayashi, T., Nakagawa, A., Tanaka, T.

“…Abstract only…”
Get full text

Prediction of improvement of protein crystal quality grown in microgravity by Tanaka, H., Sato, M., Inaka, K., Yan, B., Takahashi, S., Yamanaka, M., Furubayashi, N., Sano, S., Kobayashi, T., Nakagawa, A., Tanaka, T.

“…Abstract only…”
Get full text

Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma by Furubayashi, Nobuki, Negishi, Takahito, Miura, Akihiro, Nakamura, Nobutaka, Nakamura, Motonobu

“…To evaluate the organ-specific therapeutic effect of paclitaxel and carboplatin (TC) chemotherapy in patients who failed platinum-based chemotherapy and…”
Get full text

The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab by Furubayashi, Nobuki, Minato, Akinori, Negishi, Takahito, Sakamoto, Naotaka, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Tamura, Shingo, Kuroiwa, Kentaro, Seki, Narihito, Fujimoto, Naohiro, Nakamura, Motonobu

“…To evaluate the association of clinical outcomes with posttreatment changes in the relative eosinophil count (REC) and neutrophil-to-eosinophil ratio (NER) in…”
Get full text

The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status by Furubayashi, Nobuki, Minato, Akinori, Negishi, Takahito, Sakamoto, Naotaka, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Harada, Mirii, Tamura, Shingo, Kobayashi, Hiroki, Wada, Yamato, Kuroiwa, Kentaro, Seki, Narihito, Fujimoto, Naohiro, Nakamura, Motonobu

“…Background: To evaluate the eosinophil changes, efficacy and safety of pembrolizumab treatment in advanced urothelial carcinoma patients of older age and those…”
Get full text

Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab by Furubayashi, Nobuki, Minato, Akinori, Negishi, Takahito, Sakamoto, Naotaka, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Harada, Mirii, Tamura, Shingo, Miura, Akihiro, Komori, Hiroki, Kuroiwa, Kentaro, Seki, Narihito, Fujimoto, Naohiro, Nakamura, Motonobu

“…To evaluate the association between immune-related adverse events (irAEs) and the clinical outcomes and also between irAEs and the post-treatment changes in…”
Get full text

A dynamic light scattering system combined with a conventional chromatography for sample preparation by Furubayashi, N., Inaka, K., Shiba, K., Katayama, Y., Nakagawa, A.

“…Abstract only…”
Get full text

High-resolution crystals of human hematopoietic and lipocalin-type prostaglandin D synthases in space by Tanaka, H., Inaka, K., Tsurumura, T., Aritake, K., Sato, M., Takahashi, S., Yamanaka, M., Furubayashi, N., Hirota, E., Sano, S., Kobayashi, T., Tanaka, T., Urade, Y.

“…Abstract only…”
Get full text